This comprehensive review of research and best practice clinical management of spinal cord, neurodegenerative, and cerebral disorders is intended for both researchers and clinicians. Encompassing hereditary and acquired disorders from disease and accident, the book explores motor control disorders associated with stroke, dementia, seizure, encephalitis, and more. Covering disorders of both children and adults, the book discusses the latest advances in treatments related to neuroplasticity, neural tissue transplantation, and immunotherapy.
1. Introduction - p. 305 2. Epidemiology - p. 305 3. Neurovascular Topography and Clinical Deficits - p. 307 4. History - p. 317 5. Physical Examination - p. 317 6. Laboratory Evaluation - p. 317 7. Classification - p. 320 8. Childhood Stroke - p. 320 9. Adult Pure Motor Stroke - p. 321 10. Prognosis and Outcome - p. 325 11. Acute Stroke Management in Adults - p. 329 12. Acute Pediatric Stroke Management - p. 336 13. Rehabilitation Modalities to Enhance Stroke Recovery - p. 336 14. Conclusions - p. 338 15. Future Directions - p. 338 16. References - p. 338 17. Further reading - p. 346 18. Chapter 17: Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia - p. 349 19. Chapter 18: Pediatric neuropsychiatric disorders with motor and nonmotor phenomena - p. 367 20. Chapter 19: Essential tremor - p. 389 21. Chapter 20: Anatomy, physiology, and evaluation: Bowel, bladder, and sexual disorders - p. 403 22. Chapter 21: Isolated and combined dystonias: Update - p. 430 23. Chapter 22: Frontal lobe motor syndromes - p. 443 24. Chapter 23: Tourette syndrome and other tic disorders of childhood - p. 457 25. Chapter 24: Mild traumatic brain injury and sports-related concussion - p. 475 26. Section 4: Therapeutics - p. 493 27. Chapter 25: Treatment of spasticity - p. 497 28. Chapter 26: Novel therapeutic approaches for motor neuron disease - p. 523 29. Chapter 27: Botulinum toxin for motor disorders - p. 539 30. Chapter 28: Lysosomal storage disorders: Clinical and therapeutic aspects - p. 557 31. Chapter 29: Growth factors and molecular-driven plasticity in neurological systems - p. 569 32. Chapter 30: Applied strategies of neuroplasticity - p. 599 33. Chapter 31: Passive tau-based immunotherapy for tauopathies - p. 611 34. Index - p. 619
This comprehensive review of research and best practice clinical management of spinal cord, neurodegenerative, and cerebral disorders is intended for both researchers and clinicians. Encompassing hereditary and acquired disorders from disease and accident, the book explores motor control disorders associated with stroke, dementia, seizure, encephalitis, and more. Covering disorders of both children and adults, the book discusses the latest advances in treatments related to neuroplasticity, neural tissue transplantation, and immunotherapy.
1. Introduction - p. 305 2. Epidemiology - p. 305 3. Neurovascular Topography and Clinical Deficits - p. 307 4. History - p. 317 5. Physical Examination - p. 317 6. Laboratory Evaluation - p. 317 7. Classification - p. 320 8. Childhood Stroke - p. 320 9. Adult Pure Motor Stroke - p. 321 10. Prognosis and Outcome - p. 325 11. Acute Stroke Management in Adults - p. 329 12. Acute Pediatric Stroke Management - p. 336 13. Rehabilitation Modalities to Enhance Stroke Recovery - p. 336 14. Conclusions - p. 338 15. Future Directions - p. 338 16. References - p. 338 17. Further reading - p. 346 18. Chapter 17: Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia - p. 349 19. Chapter 18: Pediatric neuropsychiatric disorders with motor and nonmotor phenomena - p. 367 20. Chapter 19: Essential tremor - p. 389 21. Chapter 20: Anatomy, physiology, and evaluation: Bowel, bladder, and sexual disorders - p. 403 22. Chapter 21: Isolated and combined dystonias: Update - p. 430 23. Chapter 22: Frontal lobe motor syndromes - p. 443 24. Chapter 23: Tourette syndrome and other tic disorders of childhood - p. 457 25. Chapter 24: Mild traumatic brain injury and sports-related concussion - p. 475 26. Section 4: Therapeutics - p. 493 27. Chapter 25: Treatment of spasticity - p. 497 28. Chapter 26: Novel therapeutic approaches for motor neuron disease - p. 523 29. Chapter 27: Botulinum toxin for motor disorders - p. 539 30. Chapter 28: Lysosomal storage disorders: Clinical and therapeutic aspects - p. 557 31. Chapter 29: Growth factors and molecular-driven plasticity in neurological systems - p. 569 32. Chapter 30: Applied strategies of neuroplasticity - p. 599 33. Chapter 31: Passive tau-based immunotherapy for tauopathies - p. 611 34. Index - p. 619
